| abstract |
Mesenchymal stem cells, mesenchymal stem cells culture medium, actinbin A, PF4, decorin, galectin 3, GDF15, glypican 3, MFRP, ICAM5, IGFBP7, PDGF-AA, SPARCL1, thrombospondin 1, WISP1 Provided is a pharmaceutical composition for the prevention or treatment of neurological diseases, and a method therefor, comprising at least one selected from the group consisting of, progranulin, IL-4, a factor inducing expression of one or more thereof, and a combination thereof. . |